Changes in blood pressure after administration of hydroxocobalamin: relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers

Clin Toxicol (Phila). 2008 Jul;46(6):551-9; discussion 576-7. doi: 10.1080/15563650701829763.

Abstract

Objective: To assess the relationship between blood pressure changes following infusion of antidotal doses of hydroxocobalamin and plasma concentrations of total and free cobalamins-(III).

Methods: Independent groups of healthy volunteers received single intravenous doses of 2.5, 5, 7.5, or 10 g hydroxocobalamin over 7.5 to 30 minutes.

Results: In the pharmacokinetic population (n = 41), hydroxocobalamin caused short-lived mean blood pressure increases. Blood pressure increased shortly after initiation of infusion and returned nearly to baseline by 4 hours post-infusion. The time course of blood pressure changes coincided with that of changes in plasma total and free cobalamins-(III). Change in mean arterial pressure (MAP) was strongly correlated with plasma area-under-the-concentration-time curves (AUCs) of total and free cobalamins-(III) during infusion (r > 0.7) but not through 24 hours post-infusion (r < or = 0.36).

Conclusion: The short-lived increase in mean blood pressure during administration of antidotal doses of hydroxocobalamin is closely linked to initial exposure to total and free cobalamins-(III).

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidotes / administration & dosage
  • Antidotes / adverse effects*
  • Antidotes / pharmacokinetics
  • Area Under Curve
  • Blood Pressure / drug effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hydroxocobalamin / administration & dosage
  • Hydroxocobalamin / adverse effects*
  • Hydroxocobalamin / pharmacokinetics
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Poisoning / drug therapy
  • Time Factors
  • Vitamin B 12 / blood*

Substances

  • Antidotes
  • Vitamin B 12
  • Hydroxocobalamin